Ulta Beauty
ULTA
$635.01
+4.62%
Ulta Beauty is the largest specialty beauty retailer in the United States, operating more than 1,500 stores plus a scaled e-commerce platform and in-store salon services, selling cosmetics (38% of 2025 sales), skincare (24%), hair care (19%), and fragrance (13%), with a small international footprint through Space NK in the UK and Ireland, franchised stores in Mexico, and a Middle East joint venture. Its distinctive position rests on a differentiated 'beauty destination' model that combines mass and prestige brands under one roof with salon services that drive traffic and loyalty, a structural advantage versus department stores and pure-play mass retailers. The current investor debate centers on whether Ulta can sustain mid-single-digit to high-single-digit comparable growth as the U.S. beauty category normalizes after a multi-year post-pandemic boom, with recent headlines highlighting Q2 earnings and revenue beats alongside Q1 beats and a raised full-year profit outlook, but also recurring concerns about cost inflation and margin pressure that have kept the stock's rating mixed and its relative performance uneven. Management's margin trajectory, share repurchase cadence, and the durability of consumer demand in a sticky-inflation backdrop are the key swing factors framing the narrative.…
ULTA
Ulta Beauty
$635.01
Related headlines
ULTA 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Ulta Beauty's 12-month outlook, with a consensus price target around $633.44 and implied upside of -0.3% versus the current price.
Average Target
$633.44
0 analysts
Implied Upside
-0.3%
vs. current price
Analyst Count
—
covering this stock
Price Range
$500 - $731
Analyst target range
Drowning in data?
Find the real signal!
Bulls vs Bears: ULTA Investment Factors
The bull case rests on a genuine fundamental inflection: Q2 FY2026 revenue growth accelerated to 8.87% with EPS up 13.7%, ROE of 41.1%, $1.07B in TTM free cash flow, and a 33.7% rebound off the 52-week low backed by a 'buy' consensus and $631.44 average target. The bear case is equally grounded: margins remain under pressure (Q2 operating margin 12.66% versus Q1's 14.17%), the PEG of 22.87 shows the stock is expensive relative to its high-single-digit growth, and the stock still lags the S&P 500 by 16.3 points YTD. On balance the bull evidence is currently stronger because the most recent data (Q2 beat, accelerating revenue, momentum) is fresher than the margin concerns, but the margin is thin. The single most important tension is whether Ulta can hold gross margins near 39% and operating margins above 12% while sustaining ~9% revenue growth; if margins stabilize, the 18.5x forward PE is cheap, but if they slip toward the 11% operating margin seen in Q3 FY2025, the multiple will compress.
Bullish
- Analyst consensus buy with 6.5% upside: 25 analysts carry a consensus recommendation of 'buy' (mean 1.79) with an average target of $631.44 versus the current $592.94, implying roughly 6.5% upside. The high target of $731.00 implies about 23% upside, showing a meaningful cohort of analysts still sees substantial re-rating potential.
- Q2 beat with accelerating revenue growth: Q2 FY2026 revenue of $3.036B grew 8.87% year over year versus $2.788B in Q2 FY2025, an acceleration from the prior-year comparison. EPS rose to $6.57 from $5.78, a 13.7% increase, showing operating leverage despite cost concerns.
- Strong returns on capital and cash generation: ROE stands at 41.1% and ROA at 14.8%, exceptional for a specialty retailer. TTM free cash flow is $1.067B against a $29.0B market cap, a roughly 3.7% FCF yield, funding buybacks (share count fell from 46.5M diluted in Q4 FY2024 to 43.5M in Q2 FY2026).
- Momentum inflecting sharply: The stock is up 23.6% over three months and 11.8% over one month, beating the S&P 500 by 20.9 and 10.5 percentage points respectively. It has recovered from the $443.60 52-week low to $592.94, a 33.7% rebound, suggesting the market is re-rating the post-Q2 outlook.
Bearish
- Margin compression is real and recurring: Operating margin fell to 12.66% in Q2 FY2026 from 12.55% a year earlier but well below Q1 FY2026's 14.17% and Q4 FY2025's 12.33%; gross margin slipped to 39.1% from 39.15%. The Q4 FY2026 print (March 2026) dropped despite an earnings beat specifically on rising costs and margin pressure, and Q2's net margin of 9.29% is below Q1's 10.76%.
- Valuation is rich on growth-adjusted basis: Trailing PE of 25.2x and forward PE of 18.5x look reasonable, but the PEG ratio of 22.87 signals the market is paying heavily for growth that is only high-single-digit. Price-to-book of 10.35x and price-to-sales of 2.34x are premium multiples for a retailer growing revenue 8.9%.
- Underperforming the market over the year: Despite the recent rally, the stock is down 4.37% YTD versus the S&P 500's +11.93%, a relative strength gap of -16.3 points. Over 12 months it returned 10.36% versus the index's 15.53%, a -5.17 point shortfall, and it remains 17.1% below its 52-week high of $714.97.
- Earnings quality and estimate risk: The reported trailing EPS of $0.0397 in the key metrics dataset is inconsistent with quarterly diluted EPS of $5.14-$8.46, flagging data quality issues, while the PEG of 22.87 and forward PE of 18.5x on $44.40 estimated EPS imply the market already discounts the consensus. Any deceleration below the 8.9% revenue growth rate would compress the multiple quickly.
ULTA Technical Analysis
Beta
0.84
0.84x market volatility
Max Drawdown
-36.2%
Largest decline past year
52-Week Range
$444-$715
Price range past year
Annual Return
+22.3%
Cumulative gain past year
| Period | ULTA Return | S&P 500 |
|---|---|---|
| 1m | +14.7% | -1.2% |
| 3m | +33.6% | +3.4% |
| 6m | +13.7% | +7.0% |
| 1y | +22.3% | +14.4% |
| ytd | +2.4% | +12.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ULTA Fundamental Analysis
Quarterly Revenue
$3.0B
2026-08
Revenue YoY Growth
+8.9%
YoY Comparison
Gross Margin
39.1%
Latest Quarter
Free Cash Flow
$1.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ULTA Overvalued?
PE
25.2x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 12x~23x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
16.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on margin durability and cost structure. Gross margin has oscillated between 38.1% (Q4 FY2025) and 40.4% (Q3 FY2025) over the last eight quarters, and Q2 FY2026's 39.1% sits mid-range, while operating margin fell from 14.17% in Q1 FY2026 to 12.66% in Q2, a 151 basis point sequential decline. SG&A of $802.8M in Q2 grew 8.2% year over year, nearly matching the 8.9% revenue growth, leaving little cushion if wage or occupancy costs rise further. Debt-to-equity of 0.78 and a current ratio of 1.41 are manageable, but the company carries $3.68M in quarterly interest expense and has no dividend (payout ratio 0%), so total shareholder return depends entirely on buybacks and price appreciation. Revenue concentration in the U.S. market and in cosmetics (38% of sales) means a category slowdown or share loss to Amazon, e.l.f., or Sephora would hit the top line directly.
Market and competitive risks are dominated by valuation compression and sector rotation. At 25.2x trailing and 18.5x forward earnings, the stock trades at a premium to the broader retail sector, and the PEG of 22.87 leaves little room for error if growth decelerates. Beta of 0.838 offers some downside cushion, but the stock's -16.3 point YTD relative strength gap versus the S&P 500 shows it has already been a source of funds during rotations into higher-growth names. Competitive pressure from Sephora's Kohl's rollout, Amazon's beauty expansion, and mass retailers like Target and Walmart expanding prestige assortments threatens Ulta's 'beauty destination' moat. Recent headlines on sticky inflation and stagflation fears (March 2026) highlight macro sensitivity: beauty is discretionary, and a consumer spending pullback would hit comparable sales and margins simultaneously.
In a worst-case scenario, a consumer-led slowdown combines with margin compression and multiple de-rating. If revenue growth decelerates from 8.9% toward low single digits, gross margin slips below 38%, and the forward PE compresses from 18.5x toward 14x, the stock could retest its 52-week low of $443.60, roughly 25% below the current $592.94. The analyst low target of $500.00 implies about 15.7% downside, and the historical max drawdown of -36.23% shows the stock is capable of severe declines. A realistic adverse path is a Q3 or Q4 earnings miss driven by cost inflation, followed by analyst downgrades and a rotation out of consumer discretionary, producing a -25% to -30% move to the $415-$445 range.